5 Best Pharma Dividend Stocks To Buy in 2023

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 84

Johnson & Johnson (NYSE:JNJ) tops our list of the best dividend stocks from the pharma sector. The company currently offers a quarterly dividend of $1.13 per share and has a dividend yield of 2.73%, as of April 17. It holds one of the longest dividend growth streaks of 61 years.

According to Insider Monkey’s Q4 2022 database, 84 hedge funds owned investments in Johnson & Johnson (NYSE:JNJ), with a total value of over $5.5 billion. Bridgewater Associates was one of the company’s leading stakeholders in Q4.

Follow Johnson & Johnson (NYSE:JNJ)

You can also take a look at 10 Best Mid-Cap Dividend Aristocrats To Buy and 12 Best Covid Treatment Stocks to Buy Today

Follow Insider Monkey on Twitter

Page 5 of 5